ibx glp-1 ‼️🚨𝐈𝐁𝐗 𝐍𝐎 𝐋𝐎𝐍𝐆𝐄𝐑 𝐂𝐎𝐕𝐄𝐑𝐈𝐍𝐆 ‼️🚨, A letter was sent out November 1st, from one of our region’s largest health insurer regarding coverage for those taking medications for weight loss. , “Effective Independence restricts health coverage for

GLP-1

Under federal law, 503B compounding pharmacies are permitted to compound copies of FDA-approved drugs when those drugs appear on the FDA's official drug shortage list

It was semaglutide, a drug sold under the brand names Ozempic (for diabetes) and Wegovy (for weight loss)

This research highlights that there are several studies under development that may bring additional results in the continuation or replication of the use of SMG in patients with obesity and/or DM2 but also investigate new combinations (e.g., combination with dehydrated cannabidiolNCT06648031) compared to new drugs (NCT06649344, NCT06604624, NCT06579105, NCT06577090, NCT06497049, NCT06282458, and NCT05616013) and may even expand the indications for other pathological conditions (associated or not with obesity or DM2), such as steroid-induced diabetes (NCT06318442), acute myocardial infarction (NCT06557811), autosomal dominant polycystic kidney disease (NCT06582875), steatohepatitis associated with metabolic dysfunction (NCT06492330 and NCT06374875), obesity-related asthma (NCT05254314), cystic fibrosis (NCT05788965), advanced interstitial lung disease (NCT05746039), psoriasis vulgaris (NCT06475586), systemic scleroderma (NCT06149260), idiopathic intracranial hypertension (NCT06361823 and NCT06027567), post-acute stroke (NCT05630586 and NCT05920889), neuroleptic-related prediabetes in individuals with schizophrenia (NCT05193578), Alzheimers (NCT06072963 and NCT05891496), functional hypogonadism (NCT06489457), polycystic ovary syndrome (NCT05646199, NCT05702905, NCT06222437, and NCT05819853), endometrial hyperplasia (NCT05829460), Klinefelters syndrome (NCT05586802), or even in alcohol consumption disorder (NCT05520775, NCT05891587, NCT05895643, and NCT05892432), opioid use (NCT06548490), or cocaine use with and without human immunodeficiency virus (NCT06691243), among many other potential therapeutic indications

Its a good idea to take stock of these basic nutrients and use supplements to replace them as needed

Understanding of the impact on recurrence-free survival is more limited, as it has not looked at long term, so those results were particularly striking. Among women with type 2 diabetes, those who used GLP-1 agents exhibited lower risks for all-cause mortality (HR = 0.09